Larson Financial Group LLC Buys 199 Shares of Colgate-Palmolive (NYSE:CL)

Larson Financial Group LLC increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 25.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 994 shares of the company’s stock after acquiring an additional 199 shares during the quarter. Larson Financial Group LLC’s holdings in Colgate-Palmolive were worth $90,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Intellectus Partners LLC bought a new position in Colgate-Palmolive during the fourth quarter worth $753,000. AMF Tjanstepension AB boosted its stake in Colgate-Palmolive by 1,088.8% during the fourth quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock worth $233,584,000 after acquiring an additional 2,353,268 shares in the last quarter. Generali Investments CEE investicni spolecnost a.s. bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $2,236,000. Bank Julius Baer & Co. Ltd Zurich lifted its stake in shares of Colgate-Palmolive by 7.4% in the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 6,620 shares of the company’s stock valued at $664,000 after buying an additional 458 shares in the last quarter. Finally, Bradyco Inc. bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $739,000. 80.41% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CL has been the topic of a number of recent research reports. Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Piper Sandler dropped their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Barclays dropped their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Finally, StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $101.61.

Colgate-Palmolive Stock Performance

NYSE CL opened at $90.71 on Thursday. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a 50-day simple moving average of $89.03 and a 200 day simple moving average of $94.96. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The company has a market capitalization of $73.61 billion, a PE ratio of 25.77, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm earned $0.87 earnings per share. On average, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.